{
    "clinical_study": {
        "@rank": "38325", 
        "acronym": "LESS-E", 
        "arm_group": [
            {
                "arm_group_label": "Single-port surgery group", 
                "arm_group_type": "Experimental", 
                "description": "Single-port laparoscopic surgical staging including total hysterectomy, pelvic lymph node dissection, and/or bilateral salpingooophorectomy, and/or para-aortic lymph node dissection"
            }, 
            {
                "arm_group_label": "Four-port surgery group", 
                "arm_group_type": "Active Comparator", 
                "description": "Four-port laparoscopic surgical staging including total hysterectomy, pelvic lymph node dissection, and/or bilateral salpingooophorectomy, and/or para-aortic lymph node dissection"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the feasibility, safety, and efficacy between single-port and four-port\n      laparoscopic surgical staging in patients with early stage endometrial cancer."
        }, 
        "brief_title": "Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer", 
        "condition": "Endometrial Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Endometrial Neoplasms", 
                "Sarcoma, Endometrial Stromal"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Previously untreated, histologically confirmed endometrial cancer\n\n          -  Presumed FIGO stage 1\n\n          -  Endometrioid adenocarcinoma\n\n          -  patient who is planned to undergo surgical staging\n\n          -  adequate oran function\n\n               1. WBC > 3000 cells/mcl\n\n               2. Platelets > 100000/mcl\n\n               3. Creatinine < 2.0 mg/dL\n\n               4. Bilirubin < 1.5 * normal and SGOT or SGPT < 3 * normal\n\n          -  American Society of Anesthesiologists Physical Status I-II\n\n          -  Eastern Cooperative Oncology Group performance status 0-2\n\n          -  Patients who have signed an approved Informed Consent\n\n        Exclusion Criteria:\n\n          -  Uncontrolled medical disease\n\n          -  Active infectious disease requiring antibiotics\n\n          -  Previous pelvic radiation therapy\n\n          -  Pregnant and lactating woman\n\n          -  Patient who requires additional surgical procedures which are not necessary for\n             surgical staging of endometrial cancer"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679522", 
            "org_study_id": "LESS-E"
        }, 
        "intervention": [
            {
                "arm_group_label": "Single-port surgery group", 
                "description": "single-port laparoscopic surgical staging indluding total hysterectomy, pelvic lymph node dissection, and/or bilateral salpingooophorectomy, and/or para-aortic lymph node dissection", 
                "intervention_name": "single-port laparoscopic surgical staging", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Four-port surgery group", 
                "description": "Four-port laparoscopic surgical staging indluding total hysterectomy, pelvic lymph node dissection, and/or bilateral salpingooophorectomy, and/or para-aortic lymph node dissection", 
                "intervention_name": "Four-port laparoscopic surgical staging", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "endometrial cancer", 
            "laparoscopic surgical staging", 
            "single-port", 
            "four-port"
        ], 
        "lastchanged_date": "September 8, 2012", 
        "location": {
            "contact": {
                "email": "jhnam@amc.seoul.kr", 
                "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
                "phone": "82-2-3010-3633"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Jong-Hyeok Kim, M.D., Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Dae-Yeon Kim, M.D., Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jeong-Yeol Park, M.D., Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Comparison of Single-port and Four-port Laparoscopic Staging Operation for Endometrial Cancer", 
        "overall_contact": {
            "email": "jhnam@amc.seoul.kr", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "phone": "82-10-3010-3633"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Asan Medical Center Institutional Review Borad", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "operating time", 
                "safety_issue": "No", 
                "time_frame": "1 day (Immediately after operation)"
            }, 
            {
                "measure": "Number of lymph nodes retrieved", 
                "safety_issue": "No", 
                "time_frame": "1 week after surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679522"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Joo-Hyun Nam", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Postoperative pain", 
                "safety_issue": "No", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "Postoperative analgesics requirement", 
                "safety_issue": "No", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "within 6 months aftr surgery"
            }, 
            {
                "measure": "surgical stress response", 
                "safety_issue": "No", 
                "time_frame": "within 2 days after surgery"
            }, 
            {
                "measure": "transfusion requirement and amount", 
                "safety_issue": "Yes", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "postoperative complication", 
                "safety_issue": "Yes", 
                "time_frame": "within 1 month after surgery"
            }, 
            {
                "measure": "time interval to return to work", 
                "safety_issue": "No", 
                "time_frame": "within 2 months after surgery"
            }, 
            {
                "measure": "recurrence free survival", 
                "safety_issue": "No", 
                "time_frame": "2 year after surgery"
            }, 
            {
                "measure": "overall survival", 
                "safety_issue": "No", 
                "time_frame": "2 years after surgery"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}